Ronald Peck
Impact in
- Oncology top 2%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 13
- Cancer Treatment and Pharmacology 11
- Cancer Immunotherapy and Biomarkers 2
-
- Phytochemical Studies and Bioactivities 1
- Cancer therapeutics and mechanisms 1
- Co-authors
- Linda T. Vahdat (4 shared papers)Eva Thomas (2 shared papers)Gabriel N. Hortobágyi (3 shared papers)Edith A. Perez (2 shared papers)Joseph A. Sparano (3 shared papers)Patrice Viens (1 shared paper)Brian P. Mullaney (1 shared paper)Guillermo Lerzo (1 shared paper)
- Journals
- Journal of Clinical Oncology (5 papers)Experimental Biology and Medicine (1 paper)Breast Cancer Research and Treatment (1 paper)Clinical Breast Cancer (1 paper)Lung Cancer (1 paper)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Ronald Peck
15 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 71
- Oncology 843
- Cancer Research 160
- Cell Biology 160
- Dermatology 51
- Pulmonary and Respiratory Medicine 138
Countries citing papers authored by Ronald Peck
This map shows the geographic impact of Ronald Peck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald Peck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald Peck more than expected).
Fields of papers citing papers by Ronald Peck
This network shows the impact of papers produced by Ronald Peck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald Peck. The network helps show where Ronald Peck may publish in the future.
Co-authors
The 25 scholars most cited alongside Ronald Peck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 302 | |
| 2 | 2010 | 178 | |
| 3 | 2007 | 174 | |
| 4 | 2018 | 157 | |
| 5 | 2007 | 109 | |
| 6 | 2007 | 77 | |
| 7 | 2014 | 48 | |
| 8 | 2008 | 48 | |
| 9 | 1981 | 26 | |
| 10 | 2011 | 19 | |
| 11 | 2010 | 19 | |
| 12 | 2003 | 15 | |
| 13 | 2016 | 10 | |
| 14 | 2011 | 9 | |
| 15 | 2008 | 7 |
About Ronald Peck
Ronald Peck is a scholar working on Oncology, Molecular Biology, Immunology, Cardiology and Cardiovascular Medicine and Hematology, having authored 15 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (2 papers), Phytochemical Studies and Bioactivities (1 paper), Cardiac electrophysiology and arrhythmias (1 paper), Nitric Oxide and Endothelin Effects (1 paper), Multiple Myeloma Research and Treatments (1 paper) and Cancer therapeutics and mechanisms (1 paper). The work is most often cited by research in Oncology (843 citations), Cancer Research (160 citations), Cell Biology (160 citations), Dermatology (51 citations) and Pulmonary and Respiratory Medicine (138 citations). Ronald Peck has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Linda T. Vahdat, Eva Thomas, Gabriel N. Hortobágyi, Edith A. Perez, Joseph A. Sparano, Patrice Viens, Brian P. Mullaney, Guillermo Lerzo, Can Cai and Linda D. Bosserman. Their work appears in journals such as Journal of Clinical Oncology, Experimental Biology and Medicine, Breast Cancer Research and Treatment, Clinical Breast Cancer and Lung Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.